NO905591D0 - Fremgangsmaate for fremstilling av terapeutisk aktive aminopyrimidin-karboksamider. - Google Patents

Fremgangsmaate for fremstilling av terapeutisk aktive aminopyrimidin-karboksamider.

Info

Publication number
NO905591D0
NO905591D0 NO905591A NO905591A NO905591D0 NO 905591 D0 NO905591 D0 NO 905591D0 NO 905591 A NO905591 A NO 905591A NO 905591 A NO905591 A NO 905591A NO 905591 D0 NO905591 D0 NO 905591D0
Authority
NO
Norway
Prior art keywords
aminopyrimidine
carboxamides
procedure
preparation
therapeutic active
Prior art date
Application number
NO905591A
Other languages
English (en)
Other versions
NO905591L (no
NO178968B (no
NO178968C (no
Inventor
Pascal George
Philippe Manoury
Jacques Froissant
Jean-Pierre Merly
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Publication of NO905591D0 publication Critical patent/NO905591D0/no
Publication of NO905591L publication Critical patent/NO905591L/no
Publication of NO178968B publication Critical patent/NO178968B/no
Publication of NO178968C publication Critical patent/NO178968C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
NO905591A 1989-12-28 1990-12-27 Analogifremgangsmåte for fremstilling av terapeutisk aktive aminopyrimidin-karboksamidderivater NO178968C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8917304A FR2656609B1 (fr) 1989-12-28 1989-12-28 Derives de 2-aminopyrimidine-4-carboxamide, leur preparation et leur application en therapeutique.

Publications (4)

Publication Number Publication Date
NO905591D0 true NO905591D0 (no) 1990-12-27
NO905591L NO905591L (no) 1991-07-01
NO178968B NO178968B (no) 1996-04-01
NO178968C NO178968C (no) 1996-07-10

Family

ID=9389050

Family Applications (1)

Application Number Title Priority Date Filing Date
NO905591A NO178968C (no) 1989-12-28 1990-12-27 Analogifremgangsmåte for fremstilling av terapeutisk aktive aminopyrimidin-karboksamidderivater

Country Status (22)

Country Link
US (1) US5164397A (no)
EP (1) EP0435749B1 (no)
JP (1) JP2515434B2 (no)
KR (1) KR910011841A (no)
AT (1) ATE132859T1 (no)
AU (1) AU630777B2 (no)
CA (1) CA2033303A1 (no)
CS (1) CS405291A3 (no)
DE (1) DE69024778T2 (no)
DK (1) DK0435749T3 (no)
ES (1) ES2084015T3 (no)
FI (1) FI94953C (no)
FR (1) FR2656609B1 (no)
GR (1) GR3019508T3 (no)
HU (1) HU207515B (no)
IE (1) IE72954B1 (no)
IL (1) IL96815A (no)
MX (1) MX172953B (no)
NO (1) NO178968C (no)
NZ (1) NZ236605A (no)
PT (1) PT96381B (no)
ZA (1) ZA9010412B (no)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2667317B1 (fr) * 1990-10-02 1992-12-04 Synthelabo Derives de 2-aminopyrimidine-4-carboxamide, leur preparation et leur application en therapeutique.
FR2678271B1 (fr) * 1991-06-27 1995-01-13 Synthelabo Derives de pyrimidine-4-carboxamide, leur preparation et leur application en therapeutique.
FR2678272B1 (fr) * 1991-06-27 1994-01-14 Synthelabo Derives de 2-aminopyrimidine-4-carboxamide, leur preparation et leur application en therapeutique.
CZ279305B6 (cs) * 1992-01-24 1995-04-12 Lonza A.G. Kyseliny 2-halogen pyrimidin-4-karboxylové, způsob jejich přípravy a jejich použití pro přípravu derivátů substituovaných pyrimidinů-4-karboxylový ch kyselin
US5474994A (en) * 1992-05-26 1995-12-12 Recordati S.A., Chemical And Pharmaceutical Company Bicyclic heterocyclic derivatives having α1 -adrenergic and 5HT1A
IT1254469B (it) * 1992-02-25 1995-09-25 Recordati Chem Pharm Derivati benzopiranici e benzotiopiranici
FR2699171B1 (fr) * 1992-12-14 1995-02-03 Synthelabo Dérivés de 2-amino-N[[[4-aminocarbonyl) pyrimidin-2-yl]amino]alkyl]pyrimidine-4-carboxamide, leur préparation et leur application en thérapeutique.
FR2693195B1 (fr) * 1992-07-03 1994-09-23 Synthelabo Dérivés de 2-amino-N-[[[(4-aminocarbonyl)pyrimidin-2-yl]amino]alkyl] pyrimidine-4-carboxamide, leur préparation et leur application en thérapeutique.
EP0577470B1 (fr) * 1992-07-03 1995-05-24 Synthelabo Dérivés de 2-amino-N-[[[4-(aminocarbonyl)pyrimidin-2-yl]-amino]alkyl]pyrimidine-4-carboxamide, leur préparation et leur application en thérapeutique
FR2703355B1 (fr) * 1993-03-29 1995-05-05 Synthelabo Dérivés de 2-aminopyrimidine-4-carboxamide, leur préparation et leur application en thérapeutique.
FR2705344B1 (fr) * 1993-05-17 1995-06-30 Synthelabo Dérivés de 2-aminopyrazine-5-carboxamide, leur préparation et leur application en thérapeutique.
FR2724383B1 (fr) * 1994-09-13 1996-10-18 Synthelabo Derives de 2-aminopyrimidine-4-carboxamide, leur preparation et leur application en therapeutique
US5688795A (en) * 1994-11-08 1997-11-18 Syntex (U.S.A.) Inc. 3-(4-phenylpiperazin-1-yl)propyl-amino, thio and oxy!-pyridine, pyrimidine and benzene derivatives as α1 -adrenoceptor antagonists
FR2744722B1 (fr) * 1996-02-14 1998-03-13 Synthelabo Devires de 2-((3-(piperazin-1-yl)propyl)amino)pyrimidine-4- carboxamide et leur application en therapeutique
TW593290B (en) 1996-05-10 2004-06-21 Janssen Pharmaceutica Nv Alkylaminobenzothiazole and -benzoxazole derivatives
ITMI20010164A1 (it) * 2001-01-30 2002-07-30 Recordati Chem Pharm Alfa 1 antagonisti selettivi a + d
AR078793A1 (es) 2009-10-27 2011-12-07 Orion Corp Derivados de carboxamidas no esteroidales y acil hidrazona moduladores de receptores androgenicos de tejido selectivo (sarm), composiciones farmaceuticas que los contienen y uso de los mismos en el tratamiento del cancer de prostata entre otros
US9951088B2 (en) * 2012-05-09 2018-04-24 Sunovion Pharmaceuticals Inc. D2 receptor modulators and methods of use thereof in the treatment of diseases and disorders

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE787126A (fr) * 1971-08-04 1973-02-05 Byk Gulden Lomberg Chem Fab Pyrimidines substituees, procedes de preparation de ces composes et medicaments contenant lesdits composes
DE2143730A1 (de) * 1971-09-01 1973-03-08 Byk Gulden Lomberg Chem Fab Substituierte pyridine, verfahren zu deren herstellung und sie enthaltende arzneimittel

Also Published As

Publication number Publication date
AU6845190A (en) 1991-07-04
FR2656609A1 (fr) 1991-07-05
FI94953C (fi) 1995-11-27
DE69024778D1 (de) 1996-02-22
EP0435749B1 (fr) 1996-01-10
NO905591L (no) 1991-07-01
CS405291A3 (en) 1992-04-15
GR3019508T3 (en) 1996-07-31
US5164397A (en) 1992-11-17
FI906408A0 (fi) 1990-12-27
IL96815A (en) 1996-06-18
NO178968B (no) 1996-04-01
JP2515434B2 (ja) 1996-07-10
EP0435749A1 (fr) 1991-07-03
IL96815A0 (en) 1991-09-16
FI94953B (fi) 1995-08-15
ES2084015T3 (es) 1996-05-01
KR910011841A (ko) 1991-08-07
DE69024778T2 (de) 1996-09-19
ATE132859T1 (de) 1996-01-15
PT96381A (pt) 1991-10-15
AU630777B2 (en) 1992-11-05
IE72954B1 (en) 1997-05-07
NZ236605A (en) 1992-08-26
DK0435749T3 (da) 1996-05-20
HUT56092A (en) 1991-07-29
FR2656609B1 (fr) 1992-03-27
NO178968C (no) 1996-07-10
PT96381B (pt) 1998-06-30
MX172953B (es) 1994-01-25
JPH04139173A (ja) 1992-05-13
ZA9010412B (en) 1991-10-30
HU207515B (en) 1993-04-28
CA2033303A1 (en) 1991-06-29
FI906408A (fi) 1991-06-29
IE904719A1 (en) 1991-07-17

Similar Documents

Publication Publication Date Title
NO905591L (no) Fremgangsmaate for fremstilling av terapeutisk aktive aminopyrimidin-karboksamider.
HUP0101999A2 (hu) 4-Hidroxi-kinolin-3-karboxamid- és -hidrazid-származékok, ezeket tartalmazó gyógyászati készítmények, valamint e vegyületek alkalmazása
DE69214466D1 (de) Polymerbeschichtung
FI922983A0 (fi) Pyrimidin-4-karboxamidderivat, framstaellning av dessa och terapeutisk anvaendning av dessa.
DK132188D0 (da) Anvendelse af tetrahydrobenz(c,d)indol-6-carboxamider som anxiolytika
NO933611L (no) Anti-tumor- og anti-psoriatiske midler
FI913713A0 (fi) Nya bicykliska aminosubstituerade foereningar.
TW336929B (en) Benzenesulphonamide derivatives, their preparation and their application in therapy
NO890691D0 (no) Fremgangsmaate for fremstilling av nye basiske substituerte 5-halogen-tienoisotiazol-3(2h)-on-1,1-dioksider og farmasoeytiske preparater derav.
NO890158D0 (no) Fremgangsmaate for fremstilling av hydroksialkyleringsmiddel, de oppnaadde midler og deres anvendelse.
ES555030A0 (es) Procedimiento para la obtencion de nuevos derivados de isoxazol
ATE63309T1 (de) 2,3-dihydro-2-oxo-3-benzofuranylessigs|urederivate und diese enthaltende arzneimittel.
ES2077376T3 (es) Derivados de 2-aminopirimidina-4-carboxamida, su preparacion y su aplicacion terapeutica.
NO903585D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1,3-oksaziner.